Bladder Cancer Advocacy Network

Creating better todays and more tomorrows for bladder cancer patients and families since 2005.

[Margo R. Wickersham @MargoWickersham]

On Veterans Day, a practical message from a bladder cancer survivor and patient advocate:
Bladder cancer is the 4th most common cancer among U.S. veterans, and many eligible veterans and families still don't know about the benefits available to them.
The VA now treats bladder cancer as a presumptive condition for veterans exposed to Agent Orange, for those who served at least 30 days at Camp Lejeune between 1953 and 1987, and for burn pit and other toxic exposures under the PACT Act. With a presumptive condition, the veteran doesn't have to prove that service caused the cancer.
One thing that often gets missed: veterans who were denied a bladder cancer claim in the past may be able to file again.
If you work with veterans, employ them, or love one, please pass this along.
• VA toxic exposure eligibility: https://t.co/8lViPpvZFr
• PACT Act: https://t.co/M3U2B7LDC3
• BCAN veteran resources: https://t.co/Z6xW13VVwR
I lost a cousin who served in Vietnam. To every veteran: thank you for serving our country.
#VeteransDay #BladderCancer #PatientAdvocacy #PACTAct #Veterans

[Chris Parente 🇺🇸 @chrisparente]

If there’s blood 🩸 in the bowl 🚽.. you gotta ROLL! Know the symptoms 👍

[Bladder Cancer Advocacy Network @BladderCancerUS]

Watch webinars and listen to podcasts about veterans and bladder cancer:
https://t.co/yHsZ8cG5RS

[Bladder Cancer Advocacy Network @BladderCancerUS]

DYK military veterans are at an increased risk of bladder cancer due to chemical and environmental exposures?

[Bladder Cancer Advocacy Network @BladderCancerUS]

This Veterans Day, share BCAN’s educational conversations for veterans facing bladder cancer and the people who care for them.

[Bladder Cancer Advocacy Network @BladderCancerUS]

"How well a bladder tumor is removed at the initial operation shapes how accurately we can stage the cancer and plan what comes next for the patient" -@UroCancerMD

[Urology Times @UrologyTimes]

The @FDA has granted De Novo authorization to the Virtuoso Endoscopy System, a transurethral robotic platform designed to facilitate en bloc resection of bladder lesions in adults. @UroCancerMD @jteoh_hk https://t.co/4VbkJraF47

[Bladder Cancer Advocacy Network @BladderCancerUS]

@chrisparente Looking forward to the finished product! 👨

[Bladder Cancer Advocacy Network @BladderCancerUS]

Week two of Bladder Health Awareness Month focuses on bladder cancer. Share BCAN’s signs and symptoms resource to support patient conversations about blood in the urine and other urinary changes.

https://t.co/7ntKJaASiF

[Bladder Cancer Advocacy Network @BladderCancerUS]

Watch: @UroBiehn discuss considerations for selecting BCG plus durvalumab (Imfinzi) in patients with BCG-naive, high-risk NMIBC on @onclive https://t.co/fF3aL6ZRQ5

[Bladder Cancer Advocacy Network @BladderCancerUS]

Thank you @KSMurrayUro for emphasizing the importance of including patients in the decision-making process for bladder cancer treatment!

[Urology Times @UrologyTimes]

Patient priorities and practice logistics should guide therapy selection in BCG-unresponsive NMIBC, according to Katie S. Murray, DO, MS, FACS, (@KSMurrayUro) at #LUGPA2026. | @UrologyUS https://t.co/w9UcgbePz6

[Urology Times @UrologyTimes]

ESMO 2026 GU recap: PROTEUS, DASL-HiCaP, CAPItello-281, VOLGA, POTOMAC, PE-PE, and LITESPARK-011.

The prostate, bladder, and kidney cancer data to know ↓
https://t.co/utYJdSyHzL

#ESMO26 #GUOnc

[Bladder Cancer Advocacy Network @BladderCancerUS]

We know that smokers face a higher risk of bladder cancer, but what about occasional smokers? This study suggests that their risk is higher too. https://t.co/KN49pNIFNQ @IARCWHO

[Bladder Cancer Advocacy Network @BladderCancerUS]

@JoshMeeks and @UroDocAsh discuss de-escalation of therapy in MIBC and Metastatic Bladder Cancer After EV-Pembrolizumab and BCAN's Think Tank 2026: https://t.co/esbkDOsKnm

[Bladder Cancer Advocacy Network @BladderCancerUS]

@mistervee_3 @brady_urology That totally makes sense! You're not alone there.

[Bladder Cancer Advocacy Network @BladderCancerUS]

Do your cancer patients talk about sleep problems? Share this @brady_urology webinar that will explore the relationship between quality sleep and healing from cancer.

[The Johns Hopkins Brady Urological Institute @brady_urology]

Join @HopkinsGBCI and @BladderCancerUS on November 17 from 4-5 pm for the next GBCI Grand Rounds with Charlene Gamaldo, MD, Professor of Neurology, for an insightful discussion on the powerful connection between sleep and cancer recovery.

Register now: https://t.co/7Srht7MHLI

[Bladder Cancer Advocacy Network @BladderCancerUS]

Advance registration required: https://t.co/qb5onaqocc

[Bladder Cancer Advocacy Network @BladderCancerUS]

Help your patients connect with education and support. BCAN’s free Spring Bladder Cancer Summit for Patients and Families is March 5–6, 2027, in Tampa, FL.

Please share with patients and caregivers.

[Bladder Cancer Advocacy Network @BladderCancerUS]

What are the most common questions patients have after a bladder cancer diagnosis? @saumyg answers on @cure_today https://t.co/kPEVeCc6mU

[Bladder Cancer Advocacy Network @BladderCancerUS]

@chrisparente Always sending healing your way! You've got this!